Literature DB >> 12183649

Chronic self-administration of nicotine in rats impairs T cell responsiveness.

Roma Kalra1, Shashi P Singh, Dean Kracko, Shannon G Matta, Burt M Sharp, Mohan L Sopori.   

Abstract

Chronic exposure of rodents to nicotine via subcutaneously or intracerebroventricularly implanted miniosmotic pumps affects T cell function. However, this method of continuous nicotine administration does not replicate the self-motivated administration of nicotine in human smokers. To determine whether nicotine impairs the immune system under conditions pertinent to human smokers, we investigated the T cell responsiveness of male Lewis rats self-administering (SA) nicotine (0.03 mg/kg of body weight per injection) 40 to 50 times/day for 5 weeks, using a model of virtually unlimited access to nicotine. Compared with sham control animals, the concanavalin A-induced proliferation of spleen cells from SA rats was significantly decreased. Moreover, the ability of spleen cells to mobilize intracellular Ca(2+) after ligation of the T cell antigen receptor (TCR) with an anti-alphabeta TCR antibody was significantly less in SA than in control rats. In addition, inositol 1,4,5-trisphosphate (IP(3))-sensitive intracellular Ca(2+) stores were markedly depleted in spleen cells from SA animals. These results suggest that chronic nicotine self-administration suppresses T cell responsiveness, and this suppression may result from an impaired TCR-mediated signaling that stems from the depletion of IP(3)-sensitive intracellular Ca(2+) stores.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12183649     DOI: 10.1124/jpet.302.3.935

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Prenatal nicotinic exposure prolongs superior laryngeal C-fiber-mediated apnea and bradycardia through enhancing neuronal TRPV1 expression and excitation.

Authors:  Xiuping Gao; Lei Zhao; Jianguo Zhuang; Na Zang; Fadi Xu
Journal:  FASEB J       Date:  2017-06-14       Impact factor: 5.191

2.  From the Cover: Prenatal Nicotinic Exposure Attenuates Respiratory Chemoreflexes Associated With Downregulation of Tyrosine Hydroxylase and Neurokinin 1 Receptor in Rat Pup Carotid Body.

Authors:  Lei Zhao; Jianguo Zhuang; Xiuping Gao; Chunyan Ye; Lu-Yuan Lee; Fadi Xu
Journal:  Toxicol Sci       Date:  2016-06-21       Impact factor: 4.849

3.  Auto/paracrine control of inflammatory cytokines by acetylcholine in macrophage-like U937 cells through nicotinic receptors.

Authors:  Alexander I Chernyavsky; Juan Arredondo; Maryna Skok; Sergei A Grando
Journal:  Int Immunopharmacol       Date:  2009-12-18       Impact factor: 4.932

Review 4.  Electronic Cigarettes: Their Constituents and Potential Links to Asthma.

Authors:  Phillip W Clapp; Ilona Jaspers
Journal:  Curr Allergy Asthma Rep       Date:  2017-10-05       Impact factor: 4.806

5.  Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity.

Authors:  Johann Steiner; Roland Jacobs; Benjamin Panteli; Mareike Brauner; Kolja Schiltz; Sabine Bahn; Marlis Herberth; Sabine Westphal; Tomasz Gos; Martin Walter; Hans-Gert Bernstein; Aye Mu Myint; Bernhard Bogerts
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-01-27       Impact factor: 5.270

6.  Prolongation of bronchopulmonary C-fiber-mediated apnea by prenatal nicotinic exposure in rat pups: role of 5-HT3 receptors.

Authors:  Lei Zhao; Xiuping Gao; Jianguo Zhuang; Morgan Wallen; Shuguang Leng; Fadi Xu
Journal:  FASEB J       Date:  2019-06-27       Impact factor: 5.834

Review 7.  Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's disease.

Authors:  George E Barreto; Alexander Iarkov; Valentina Echeverria Moran
Journal:  Front Aging Neurosci       Date:  2015-01-09       Impact factor: 5.750

8.  Prenatal nicotinic exposure upregulates pulmonary C-fiber NK1R expression to prolong pulmonary C-fiber-mediated apneic response.

Authors:  Lei Zhao; Jianguo Zhuang; Na Zang; Yong Lin; Lu-Yuan Lee; Fadi Xu
Journal:  Toxicol Appl Pharmacol       Date:  2015-10-30       Impact factor: 4.460

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.